Millennium Management’s Capricor Therapeutics CAPR Stock Holding History

Millennium Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.63M	Sell	233,926 -122,428	-34%	-$3.71M	﹤0.01%	2879
2026 Q1	$10.8M	Sell	356,354 -325,990	-48%	-$8.69M	﹤0.01%	2096
2025 Q4	$19.7M	Buy	682,344 +479,885	+237%	+$6.27M	0.01%	1594
2025 Q3	$1.46M	Buy	202,459 +28,611	+16%	+$211K	﹤0.01%	4328
2025 Q2	$1.73M	Sell	173,848 -48,222	-22%	-$509K	﹤0.01%	4009
2025 Q1	$2.11M	Buy	222,070 +106,428	+92%	+$1.48M	﹤0.01%	3726
2024 Q4	$1.6M	Buy	115,642 +20,885	+22%	+$366K	﹤0.01%	3815
2024 Q3	$1.44M	Sell	94,757 -384,753	-80%	-$1.9M	﹤0.01%	3985
2024 Q2	$2.29M	Buy	479,510 +186,469	+64%	+$1.04M	﹤0.01%	3428
2024 Q1	$1.99M	Buy	293,041 +272,003	+1,293%	+$1.32M	﹤0.01%	3744
2023 Q4	$103K	Sell	21,038 -23,750	-53%	-$77.3K	﹤0.01%	5342
2023 Q3	$153K	Buy	+44,788	New	+$252K	﹤0.01%	5217
2023 Q1	–	Sell	-52,728	Closed	-$204K	–	6401
2022 Q4	$204K	Buy	52,728 +25,440	+93%	+$121K	﹤0.01%	5324
2022 Q3	$164K	Buy	+27,288	New	+$140K	﹤0.01%	5761
2021 Q3	–	Sell	-13,544	Closed	-$69K	–	6805
2021 Q2	$69K	Sell	13,544 -8,846	-40%	-$37.5K	﹤0.01%	6323
2021 Q1	$105K	Sell	22,390 -26,967	-55%	-$155K	﹤0.01%	5680
2020 Q4	$169K	Buy	+49,357	New	+$214K	﹤0.01%	4904
2016 Q3	–	Sell	-1,857	Closed	-$73K	–	3280
2016 Q2	$73K	Hold	1,857	–	–	﹤0.01%	3052
2016 Q1	$47K	Hold	1,857	–	–	﹤0.01%	3154
2015 Q4	$57K	Hold	1,857	–	–	﹤0.01%	3300
2015 Q3	$75K	Hold	1,857	–	–	﹤0.01%	3306
2015 Q2	$94K	Hold	1,857	–	–	﹤0.01%	3177
2015 Q1	$160K	Buy	+1,857	New	+$160K	﹤0.01%	3339

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management's CAPR Position: Q2 2026 in Review

Millennium Management reduced its Capricor Therapeutics (CAPR) stake by 34% in Q2 2026, selling an estimated $3.71M and leaving 233,926 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Millennium Management first reported a position in CAPR in Q1 2015 and has held it in 23 quarters since. The position peaked at $19.7M in Q4 2025. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Millennium Management held 233,926 shares of Capricor Therapeutics worth $5.63M as of Q2 2026.
Millennium Management sold 122,428 Capricor Therapeutics shares in Q2 2026, an estimated $3.71M.
Capricor Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2879 holding.
Millennium Management first reported a position in Capricor Therapeutics in Q1 2015 and has held it in 23 quarters since.
Millennium Management's Capricor Therapeutics position peaked at $19.7M in Q4 2025.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.